Chan Phillip P.'s Form 4 filing
Cytosorbents Corp (CTSO) · filed Jan 3, 2022
- Accession no.
- 0001104659-22-000566
- Filed
- Jan 3, 2022
- Trade date
- Dec 29-30, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $60.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chan Phillip P.CIK 0001442786 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 | Common Stock | PPurchaseAcquired | +100 | $4.04 | +$404 | 753,543 | Direct | |
| Dec 29, 2021 | Common Stock | PPurchaseAcquired | +9,438 | $4.05 | +$38,223.9 | 762,981 | Direct | |
| Dec 30, 2021 | Common Stock | PPurchaseAcquired | +5,462 | $4.05 | +$22,121.1 | 768,443 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.